ALLMedicine™ Angiosarcoma Of The Scalp Center
Research & Reviews 14 results
The Neuroradiology Journal; Kawaguchi M, Kato H et. al.
Mar 4th, 2021 - This study aimed to evaluate imaging findings of cutaneous angiosarcoma (cAS) of the scalp compared with those of cutaneous squamous cell carcinoma (cSCC). This study included 15 patients with primary cAS and 10 with primary cSCC of the scalp. Sev...
Technology in Cancer Research & Treatment; Mizuno T, Tomita N et. al.
Feb 1st, 2021 - We compared radiotherapy plans among helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), and intensity-modulated proton therapy (IMPT) for angiosarcoma of the scalp (AS). We conducted a planning study for 19 patients with AS. The cl...
Radiation Oncology (London, England); Inui S, Ueda Y et. al.
Jul 18th, 2020 - Total scalp irradiation presents technical and dosimetric challenges. While reports suggest that HyperArc, a new stereotactic radiosurgery planning technique applied to non-coplanar volumetric-modulated arc therapy (VMAT) technique, is associated ...
BMC Cancer; Oashi K, Shibata T et. al.
Jul 14th, 2020 - Paclitaxel is a standard of care for patients with primary cutaneous angiosarcoma of the scalp and face. However, no standard second-line treatment for paclitaxel-resistant patients has ever been established. Since primary cutaneous angiosarcoma e...
Anticancer Research; Vitolo V, Barcellini A et. al.
Mar 6th, 2020 - In inoperable patients, the management of angiosarcoma of the scalp is challenging. Due to intrinsic, dosimetric and radiobiological properties, proton beam radiotherapy may be an effective and safe option to offer to these difficult-to-cure patie...